HLA-DOA anticorps (N-Term)
Aperçu rapide pour HLA-DOA anticorps (N-Term) (ABIN1881420)
Antigène
Voir toutes HLA-DOA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 31-59, N-Term
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogène
- This HLA-DOA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 31-59 amino acids from the N-terminal region of human HLA-DOA.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- WB: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Date de péremption
- 6 months
-
-
- HLA-DOA (HLA Class II DO alpha (HLA-DOA))
-
Autre désignation
- HLA-DOA
-
Sujet
- Important modulator in the HLA class II restricted antigen presentation pathway by interaction with the HLA-DM molecule in B-cells. Modifies peptide exchange activity of HLA-DM.
-
Poids moléculaire
- 27599
-
NCBI Accession
- NP_002110
-
UniProt
- P06340
-
Pathways
- Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Antigène
-